Ask AI

Independent Conference Coverage of CROI 2026: The Latest Updates in HIV *

This program summarizes key data and highlights from the 2026 Conference on Retroviruses and Opportunistic Infections (CROI).

Share

Program Content

Activities

HIV Update 1
HIV Update Webinar 1: Independent Conference Coverage of CROI 2026
Conference Coverage
Video
Congratulations: You achieved a completion on 04/09/2022

Released: March 11, 2026

HIV Update 2
HIV Update Webinar 2: Independent Conference Coverage of CROI 2026
Conference Coverage
Video
Congratulations: You achieved a completion on 04/09/2022

Released: March 11, 2026

Activities

HIV Update Podcast
HIV Update Podcast: Independent Conference Coverage of CROI 2026
Conference Coverage
Podcast Episodes
Congratulations: You achieved a completion on 04/09/2022

Released: March 16, 2026

20 Capsule Summaries

Activities

MK 8591A 052 Wk 96 DOR and ISL
MK-8591A-052 Week 96: Switch From BIC/FTC/TAF to DOR/ISL in People Living With Virologically Suppressed HIV
Conference Coverage
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: February 25, 2026

MK 8591A 051 Wk 96
MK-8591A-051 Wk 96: Switch From Standard-of-Care ART to DOR/ISL in People Living With Virologically Suppressed HIV
Conference Coverage
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: February 25, 2026

OPERA PrEP
OPERA Cohort: PrEP Coverage and HIV Incidence With LA CAB vs Daily Oral FTC/TDF or FTC/TAF
Conference Coverage
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: February 26, 2026

ARTISTRY-1
ARTISTRY-1: Phase III Trial of Single-Tablet BIC/LEN Switch vs Complex ART Continuation in People With HIV and Virologic Suppression
Conference Coverage
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: February 26, 2026

ARTISTRY-2
ARTISTRY-2: Phase III Trial of Single-Tablet BIC/LEN Switch vs BIC/FTC/TAF Continuation in People With HIV and Virologic Suppression
Conference Coverage
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: February 26, 2026

LEN Case Series
Case Series Evaluating Long-acting Lenacapavir in People With HIV and High Baseline Resistance
Conference Coverage
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: February 26, 2026

ANRS Prevenir
ANRS Prévenir: Final Results of Prospective Observational Cohort Study of Daily or On-Demand Oral FTC/TDF HIV PrEP
Conference Coverage
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: February 27, 2026

MK-8527 PrEP
MK-8527 PrEP: Phase I-II PK Analysis to Inform Dosing for EXPrESSIVE Phase III Trial Program
Conference Coverage
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: February 27, 2026

LA CAB + RPV in Adolescents
IMPAACT 2017 Cohort 2: Wk 96 and End-of-Study Data After Switch to LA CAB + RPV in Adolescents Living With HIV
Conference Coverage
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: February 27, 2026

Lenacapavir PrEP in Adolescent and Young Women
PURPOSE 1: Long-term Follow-up of Twice-Yearly Lenacapavir PrEP in Adolescent and Young Women
Conference Coverage
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: February 27, 2026

Purpose 2 Longer Term Analysis
PURPOSE 2 Longer-Term Analysis: Phase III Trial of HIV PreP With Twice-Yearly LEN vs Daily FTC/TDF in Cisgender Men and Gender Diverse People
Conference Coverage
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: February 27, 2026

LEN Resistance Mutations in PURPOSE
PURPOSE 1 and PURPOSE 2: Randomized Blinded Phase Resistance Analysis With LEN PrEP
Conference Coverage
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: February 27, 2026

VOLITION
VOLITION Primary Analysis: Phase III Trial of Early LA CAB + RPV Switch After Achieving Virologic Suppression With DTG/3TC in Treatment-Naive Adults With HIV
Conference Coverage
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: February 27, 2026

EMBRACE
EMBRACE: 12 Mo Results With Lotivibart + LA CAB for People Living With Virologically Suppressed HIV
Conference Coverage
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: February 27, 2026

EBONI
EBONI: Real-world LA CAB PrEP Implementation Among Black Women in the United States
Conference Coverage
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: March 02, 2026

ISRs With LA ART
CLARITY: Day 190 Results of Injection-Site Reactions With Long-acting Injectable ART in Adults Without HIV
Conference Coverage
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: March 02, 2026

Weekly Oral ISL and LEN
Phase II Trial of Weekly Oral ISL + LEN for People Living With Virologically Suppressed HIV: Early and Late Switch Results 
Conference Coverage
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: March 03, 2026

PROMISE US
PROMISE-US: Phase IV Noninterventional Registry Study Evaluating Long-term Efficacy/Durability of Ibalizumab + Other ARVs in People Living With MDR HIV
Conference Coverage
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: March 03, 2026

MK8591A053 Initial DOR and ISL
MK-8591A-053: DOR/ISL vs BIC/FTC/TAF in Treatment-Naive People With HIV
Conference Coverage
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: March 03, 2026

Real world LEN
Real-world Effectiveness of Lenacapavir + Optimized Background Regimen in Heavily Treatment–Experienced People Living With HIV
Conference Coverage
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: March 04, 2026

Activities

HIV Update Expanded Slides
HIV Update Expanded Slides: Independent Conference Coverage of CROI 2026
Conference Coverage
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: March 17, 2026

《HIV 最新动态》扩展版幻灯片
《HIV 最新动态》扩展版幻灯片:2026 年 CROI 独立会议报道
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: March 27, 2026

Presentación ampliada sobre el VIH
Presentación ampliada sobre el VIH: Cobertura independiente de la CROI 2026
Conference Coverage
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: March 27, 2026

Дополненные слайды с новыми данными о ВИЧ
Дополненные слайды с новыми данными о ВИЧ: Освещение независимой конференции CROI 2026
Conference Coverage
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: March 30, 2026

Slides expandidos da atualização sobre o VIH
Slides expandidos da atualização sobre o VIH: Cobertura independente da conferência de CROI 2026 
Conference Coverage
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: March 31, 2026

Activities

HIV Prevention in Latin America
The Future of HIV Prevention in Latin America
Clinical Thought
Conference Coverage
Congratulations: You achieved a completion on 04/09/2022

Released: March 09, 2026

PrEP Implementation in Africa
Towards Accessible and Equitable PrEP Implementation in Africa
Clinical Thought
Conference Coverage
Congratulations: You achieved a completion on 04/09/2022

Released: March 16, 2026

Comorbidities and HIV Care
Crossroads: The Intersection of Comorbidities and HIV Care
Clinical Thought
Conference Coverage
Congratulations: You achieved a completion on 04/09/2022

Released: March 16, 2026

HIV Care and Prevention in France
The French Revolution of HIV Care: Implementation of PrEP and Long-Acting ART
Clinical Thought
Conference Coverage
Congratulations: You achieved a completion on 04/09/2022

Released: March 18, 2026

HIV Prevention in Canada
The Future Is Long Acting: HIV Prevention Insights for Canada From CROI
Clinical Thought
Conference Coverage
Congratulations: You achieved a completion on 04/09/2022

Released: March 18, 2026

LA PrEP at CROI 2026
Long-Acting Antiretroviral Agents for PrEP: Insights From CROI 2026
Clinical Thought
Conference Coverage
Congratulations: You achieved a completion on 04/09/2022

Released: March 25, 2026

Patient Advocate Insights for HIV Care
CROI 2026: A Patient Advocate's Perspective on Transformative Insights for HIV Care
Clinical Thought
Conference Coverage
Congratulations: You achieved a completion on 04/09/2022

Released: March 26, 2026

The Future of ART at CROI 2026
The Near Future of ART at CROI 2026: Long-Acting Agents and 2-Drug Regimens          
Clinical Thought
Conference Coverage
Congratulations: You achieved a completion on 04/09/2022

Released: March 27, 2026

CROI 2026 Management of HIV Coinfections
Advances in Management of HIV Coinfections From CROI 2026: Perspectives for Asia and Beyond
Clinical Thought
Conference Coverage
Congratulations: You achieved a completion on 04/09/2022

Released: March 31, 2026

Long Acting ART CROI 2026
Long-Acting ART for All: Real-world Updates From CROI 2026
Clinical Thought
Conference Coverage
Congratulations: You achieved a completion on 04/09/2022

Released: April 03, 2026

Faculty

cover img faculity

Iskandar Azwa, MD

Associate Professor in Infectious Diseases
Faculty of Medicine
University of Malaya
Kuala Lumpur, Malaysia

cover img faculity

Eric S. Daar, MD

Chief, Division of HIV Medicine
Harbor – UCLA Medical Center
Professor of Medicine
David Geffen School of Medicine at UCLA
Torrance, California

cover img faculity

Monica Gandhi, MD, MPH

Professor of Medicine and Associate Chief
Division of HIV, Infectious Diseases, and Global Medicine
Director, UCSF Center for AIDS Research (CFAR)
Director of HIV Special Program
"Ward 86" HIV Clinic
San Francisco General Hospital
San Francisco, California

cover img faculity

Emilia M. Jalil, MD, PhD

Tenured Researcher
Evandro Chagas National Institute of Infectious Diseases
Oswaldo Cruz Foundation (Fiocruz)
Rio de Janero, Brazil

cover img faculity

Daniel R. Kuritzkes, MD

Senior Physician
Division of Infectious Diseases
Brigham and Women’s Hospital
Harriet Ryan Albee Professor of Medicine
Harvard Medical School
Boston, Massachusetts

cover img faculity

Karine Lacombe, MD, PhD

Head of Infectious Diseases Department
St Antoine Hospital, AP-HP
Sorbonne University
Paris, France

cover img faculity

Sharon R. Lewin, AO, FRACP, PhD

Director, Doherty Institute
Melbourne Laureate Professor
University of Melbourne
Consultant Infectious Diseases Physician
Royal Melbourne Hospital and Alfred Hospital
Melbourne, Australia

cover img faculity

Jean-Michel Molina, MD

Professor of Medicine
Saint-Louis and Lariboisire Hospitals
Université Paris Cité
Paris, France

cover img faculity

Andrew Mujugira, MBChB, MSc, MPH, PhD

Senior Research Scientist
Affiliate Assistant Professor
Department of Global Health
University of Washington
Seattle, Washington

cover img faculity

Chloe Orkin, MBChB, FRCP, MD

Professor of Infection and Inequities
Dean for Healthcare Transformation
Faculty of Medicine and Dentistry
Queen Mary University of London
Honorary Consultant Physician
Barts Health NHS Trust
London, United Kingdom

cover img faculity

Aadia I. Rana, MD, FIDSA

Professor of Medicine
Division of Infectious Diseases
University of Alabama – Birmingham Heersink School of Medicine
Birmingham, Alabama

cover img faculity

L. Lorenzo Williams

Global Community Advisory Board (GCAB)
Co-Chair
Advancing Clinical Therapeutics Globally (ACTG)
National Institute of Health
New York, New York

cover img faculity

Alexander Wong, MD, FRCPC

Associate Professor of Medicine
University of Saskatchewan
Division Lead, Infectious Diseases
Regina, Saskatchewan, Canada

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC dba Decera Clinical Education

Supporters

Supported by independent educational grants from Gilead Sciences, Inc., Merck & Co., Inc., Rahway, NJ, USA, and ViiV Healthcare.

Gilead Sciences, Inc.

Merck & Co., Inc., Rahway, NJ, USA

ViiV Healthcare

*Decera Clinical Education is an independent medical education company that provides state-of-the-art medical information to healthcare professionals through conference coverage and other educational programs.